Delivery Order SPE2DB20D3103-SPE2DB26FL4H5
- Not listed
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of Darzalex Faspro 1,800mg/30,000 15ml pharmaceutical product. This firm fixed-price delivery order, valued at $239,208.40, represents a competitively awarded, non-set-aside contract with a completion deadline of October 17, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical...
- The Defense Logistics Agency awarded a $11,960.40 firm fixed-price delivery order to AmerisourceBergen Drug Corp on October 16, 2025, for the supply of Darzalex FasPro 1,800mg-30,000 (15mL) pharmaceutical product. This non-set-aside competitive award is scheduled for completion by November 6, 2025, with performance at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order represents a single transaction under AmerisourceBergen's larger Indefinite Delivery Contract with...
- The Defense Logistics Agency awarded a $17,940.63 firm fixed price delivery order to AmerisourceBergen Drug Corp for Darzalex Faspro 1,800mg-30,000 15ml pharmaceutical product on August 25, 2025, with an ultimate completion date of September 16, 2025. This is a non-set-aside competitive award with performance at the contractor's Corporate Office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $478,416.80 to AmerisourceBergen Drug Corp for Darzalex Faspro 1,800mg-30,000 15ml pharmaceutical products. This firm fixed price delivery order, awarded on September 2, 2025, represents a non-competitive, competitively awarded procurement with an ultimate completion date of September 23, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Darzalex Faspro 1,800mg-30,000 15ml pharmaceutical product. This firm fixed-price delivery order, valued at $11,960.42, represents a non-competitive, non-set-aside procurement and is scheduled for completion by August 4, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $59,802.10 delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Darzalex Faspro 1,800mg-30,000 15ml pharmaceutical product. This firm fixed-price delivery order, with an ultimate completion date of September 17, 2025, was competitively awarded without set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The contract represents a single delivery order issued under...
- The Defense Logistics Agency awarded a $11,960.42 firm fixed price delivery order to AmerisourceBergen Drug Corp for Darzalex Faspro 1,800mg-30,000 15ml pharmaceutical product, with performance scheduled for completion by October 14, 2025. This non-competitive delivery order was issued on September 22, 2025, and will be fulfilled from the vendor's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a...
- The Defense Logistics Agency awarded a $59,802.10 delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Darzalex FasPro 1,800mg-30,000 15ml pharmaceutical product. This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 11, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation, indicating the award was made through open...
- The Defense Logistics Agency (DLA) awarded a $107,643.78 delivery order to AmerisourceBergen Drug Corp on September 29, 2025, for the supply of Darzalex Faspro 1,800mg-30,000 15ml pharmaceutical product, with an ultimate completion date of October 21, 2025. This is a firm fixed price contract with no set-aside designation, competitively awarded to the prime contractor at its corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract issued under...
- The Defense Logistics Agency awarded a delivery order valued at $119,604.20 to AmerisourceBergen Drug Corp on September 24, 2025, for the supply of Darzalex Faspro 1,800mg-30,000 15ml pharmaceutical products, with completion targeted for October 16, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child order issued under AmerisourceBergen...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB26FL4H5Delivery Order
The Defense Logistics Agency awarded a $35,881.20 delivery order to AmerisourceBergen Drug Corp on October 29, 2025, for the supply of Darzalex Faspro 1,800mg/30,000 IU 15mL pharmaceutical product. This is a firm fixed price, competitively awarded contract with an ultimate completion date of November 20, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order operates under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical procurement vendor that supplies an extensive portfolio of brand-name and generic medications, vaccines, and specialized healthcare commodities to defense and veteran healthcare systems. The company's contract awards with the DLA demonstrate its capability to fulfill diverse pharmaceutical needs across multiple therapeutic domains through competitive procurement processes. This delivery order represents one of numerous small- to mid-value transactions executed under the company's prime indefinite delivery vehicle, supporting the Defense Health Agency and other federal healthcare customers worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $35.9k | 10/29/25 |